Financings in Brief: Igen
This article was originally published in The Gray Sheet
Executive Summary
Igen: Receives $6 mil. advance payment of royalties from Boehringer Mannheim, its partner in developing Igen's Origen technology for use in immunodiagnostic systems. Boehringer launched the Elecsys system, which incorporates Origen technology, in 1996. Royalties above $6 mil. will be paid separately in accordance with the collaborative agreement, Igen says. Any shortfall will be "creditable against subsequent years' royalties"...